Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma.
- Resource Type
- Article
- Authors
- Ku, Geoffrey Yuyat; Wu, Abraham Jing-Ching; Trivedi, Nikhil; Maron, Steven Brad; Joshi, Smita Suhas; Ilson, David H.; Janjigian, Yelena Y.; Shcherba, Marina; Li, Jia; Tang, Laura H.; Yeh, Randy; Sihag, Smita; Park, Bernard J.; Jones, David Randolph; Molena, Daniela
- Source
- Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p355-355, 185p
- Subject
- Language
- ISSN
- 0732183X